FDA.reportPublic FDA data

INSULIN GLARGINE

Substance profile for UNII 2ZM8CX04RZ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for INSULIN GLARGINE
Structure render from PubChem CID 118984454

Substance Identity#

UNII
2ZM8CX04RZ
Preferred term
INSULIN GLARGINE
Registry number
160337-95-1
Ingredient type
INGREDIENT SUBSTANCE
Chemical structure for INSULIN GLARGINE
Structure render from PubChem CID 118984454

Chemical And Database Identifiers#

RxCUI
274783
PubChem
118984454
NCIt
C47564
INN ID
7548

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound118984454pubchem.ncbi.nlm.nih.gov/compound/118984454
RxNorm274783mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=274783
NCI ThesaurusC47564ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47564
FDA Substance Registration System2ZM8CX04RZprecision.fda.gov/uniisearch/srs/unii/2ZM8CX04RZ

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20001
ACTIVE MOIETYThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20001
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
ACTIVE MOIETYThese highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20002
ACTIVE INGREDIENTLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]22
ACTIVE MOIETYLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION LANTUS SOLOSTAR (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]22
ACTIVE INGREDIENTTOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]7
ACTIVE MOIETYTOUJEO (INSULIN GLARGINE) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]7
ACTIVE INGREDIENTLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
ACTIVE MOIETYLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
ACTIVE INGREDIENTLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1
ACTIVE MOIETYLANTUS (INSULIN GLARGINE) INJECTION, SOLUTION [REMEDYREPACK INC. ]1